Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nanosci Nanotechnol ; 19(8): 5303-5309, 2019 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-30913848

RESUMO

In the present work, ZnO nanorods and ZnO/GO/CNT nanocomposite have been prepared by microwave assisted method using various time of incorporation of GO/CNT. The structural and optical characterizations were performed by X-ray diffraction (XRD), Scanning electron microscope (SEM), UV-Visible spectrometer (UV-Vis) and Photoluminescence (PL). The XRD data showed that the most intense peak at 36° belong to (101) plane of ZnO nanorods. SEM results showed the formation of nano rods assembled in flower like structure. UV spectra shows that the samples absorb ultraviolet light and had a band gap value of 3.1-3.2 eV. The PL spectra showed the lowest PL intensity band for ZnO/GO/CNT-A. Higher photocatalytic degradation of 91% was determined in ZnO/GO/CNT composite when GO/CNT was added at the end of the procedure.

2.
J Coll Physicians Surg Pak ; 22(4): 207-12, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22482374

RESUMO

OBJECTIVE: To determine the changes produced in serum 25OHD and iPTH levels after 600,000 IU of injection cholecalciferol in volunteers. STUDY DESIGN: Interventional study. PLACE AND DURATION OF STUDY: Section of Chemical Pathology, Department of Pathology and Microbiology, the Aga Khan University Hospital, Karachi, from June 2009 - June 2010. METHODOLOGY: Volunteers of either gender aged 18-40 years with known 25OHD, calcium (Ca), creatinine (Cr) and phosphorous (P) levels were included in the study. Subjects on therapy like vitamin D and calcium supplements, corticosteroids or anti-epileptic medicines, primary hyperparathyroidism and hypercalcaemia, with co-morbidity like renal failure, liver disease and history of malabsorption, diarrhea or hyperthyroidism were excluded. All volunteers were given an intramuscular injection of vitamin D3 (cholecalciferol, 600,000 IU). After 8 weeks, serum 25OHD, iPTH, Ca and P levels were determined again. For 25OHD level, cut-off of ² 50 nmol/l was defined as deficient, 50-75 nmol/l as insufficient and ³ 75 as optimal level. RESULTS: Mean 25OHD and iPTH levels were 35.06 ± 16.6 nmol/l and 81.15 ± 76.78 pg/ml respectively at baseline. Seventeen volunteers were 25OHD deficient. Five had high iPTH levels (25%) (mean 156 ± 123.7 pg/ml). 25OHD and iPTH showed a significant inverse correlation at baseline (< 0.01). After 8 weeks of injection vitamin D 25OHD levels became optimal in 6 subjects (35%) [mean 92.9 ± 16.6 nmol/l]. It remained low in 5 volunteers (25%) [mean 41.6 ± 9.6 nmol/l] while insufficient levels were seen in 9 volunteers (40%) [mean 63.3±5.8 nmol/l]. Follow-up mean Ca, P and iPTH were 2.25 mmol/l (± 0.09), 1.1 (± 0.1) and 47.52 pg/ml (± 22.56) respectively. A significant increase in mean 25OHD level was seen at follow-up (p < 0.01), while the change in PTH was insignificant (p=0.05). CONCLUSION: Single mega-dose of cholecalciferol achieved optimal levels of 25OHD in 35% of subjects after eight weeks of supplementation.


Assuntos
Hiperparatireoidismo Secundário/tratamento farmacológico , Hormônio Paratireóideo/sangue , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/análogos & derivados , Vitamina D/administração & dosagem , Adolescente , Adulto , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Seguimentos , Humanos , Hiperparatireoidismo Secundário/sangue , Hiperparatireoidismo Secundário/etiologia , Injeções Intramusculares , Masculino , Estudos Retrospectivos , Resultado do Tratamento , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Vitaminas/administração & dosagem , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...